中华内分泌代谢杂志
中華內分泌代謝雜誌
중화내분비대사잡지
CHINESE JOURNAL OF ENDOCRINOLOGY AND METABOLISM
2014年
6期
519-522
,共4页
刘敏%向光大%卢俊颜%董靖%向林
劉敏%嚮光大%盧俊顏%董靖%嚮林
류민%향광대%로준안%동정%향림
肿瘤坏死因子相关的凋亡诱导配体%糖尿病,实验性%动脉粥样硬化
腫瘤壞死因子相關的凋亡誘導配體%糖尿病,實驗性%動脈粥樣硬化
종류배사인자상관적조망유도배체%당뇨병,실험성%동맥죽양경화
Tumor necrosis factor-related apoptosis ligand%Diabetic mellitus,experimental%Atherosclerosis
4周龄雄性SD大鼠经高脂喂养8周后予小剂量链脲佐菌素腹腔注射以建立糖尿病模型,分为糖尿病组和瘤坏死因子相关的凋亡诱导配体(tumor necrosis factor-related apoptosis ligand,TRAIL)干预组,另选正常SD大鼠为对照组.TRAIL干预3个月.与糖尿病组相比,TRAIL干预组总胆固醇、甘油三酯、血糖、胰岛素显著降低,大鼠主动脉粥样斑块病变面积及光镜下内膜厚度减小[(23.8±5.7)%对(47.6±7.8)%].提示TRAIL可减轻糖尿病大鼠动脉粥样硬化病变.
4週齡雄性SD大鼠經高脂餵養8週後予小劑量鏈脲佐菌素腹腔註射以建立糖尿病模型,分為糖尿病組和瘤壞死因子相關的凋亡誘導配體(tumor necrosis factor-related apoptosis ligand,TRAIL)榦預組,另選正常SD大鼠為對照組.TRAIL榦預3箇月.與糖尿病組相比,TRAIL榦預組總膽固醇、甘油三酯、血糖、胰島素顯著降低,大鼠主動脈粥樣斑塊病變麵積及光鏡下內膜厚度減小[(23.8±5.7)%對(47.6±7.8)%].提示TRAIL可減輕糖尿病大鼠動脈粥樣硬化病變.
4주령웅성SD대서경고지위양8주후여소제량련뇨좌균소복강주사이건립당뇨병모형,분위당뇨병조화류배사인자상관적조망유도배체(tumor necrosis factor-related apoptosis ligand,TRAIL)간예조,령선정상SD대서위대조조.TRAIL간예3개월.여당뇨병조상비,TRAIL간예조총담고순、감유삼지、혈당、이도소현저강저,대서주동맥죽양반괴병변면적급광경하내막후도감소[(23.8±5.7)%대(47.6±7.8)%].제시TRAIL가감경당뇨병대서동맥죽양경화병변.
Four-week-old male Sprague-Dawley rats were rendered diabetic by intraperitoneal injection of streptozotocin (STZ) after feeding high-fat-diet for 8 weeks,and divided into diabetes group and tumor necrosis factorrelated apoptosis ligand(TRAIL) group.Normal rats severed as a control group.Treatment with TRAIL lasted for 3 months.Total cholesterol,triglycerides,low-density lipoprotein-cholesterol,blood glucose,and insulin levels were decreased in TRAIL group,as compared with diabetes group.Area of atherosclerotic lesion in TRAIL group [(23.8 ± 5.7) %] was significantly smaller than that in diabetes group [(47.6 ± 7.8) %].It suggested that TRAIL may reduce the area of atherosclerotic lesion in diabetic rats.